Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel (H1N1) Influenza”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00972816
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Who this might be right for
Influenza
Novartis Vaccines 1,357
Not applicableStudy completedNCT01407978
What this trial is testing

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Who this might be right for
Novel 2009 Influenza H1N1Influenza, Human
Fluart Innovative Vaccine Ltd, Hungary 58
Large-scale testing (Phase 3)Study completedNCT00996138
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 200
Not applicableStudy completedNCT01101074
What this trial is testing

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Who this might be right for
Influenza A (H1N1)
Novartis Vaccines 135,469
Large-scale testing (Phase 3)Study completedNCT00971906
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 660
Not applicableStudy completedNCT01022931
What this trial is testing

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Who this might be right for
HealthyImmunosuppressedAsthmatic+1 more
University Hospital, Geneva 200
Not applicableStudy completedNCT01046331
What this trial is testing

Novel Influenza A (H1N1) Surveillance Registry

Who this might be right for
Novel Influenza AH1N1Influenza
National Heart, Lung, and Blood Institute (NHLBI) 894
Large-scale testing (Phase 3)Study completedNCT01000207
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 123
Large-scale testing (Phase 3)Study completedNCT00971542
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 778
Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing

Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus

Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342
Not applicableStudy completedNCT01289418
What this trial is testing

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Who this might be right for
Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network 6,525
Post-approval studies (Phase 4)Study completedNCT00956111
What this trial is testing

A Clinical Trial With Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 1,614
Large-scale testing (Phase 3)UnknownNCT01040078
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Centers for Disease Control and Prevention, China 900
Testing effectiveness (Phase 2)Study completedNCT00940108
What this trial is testing

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children

Who this might be right for
Influenza Caused by the Novel Influenza A (H1N1) Virus
Seqirus 370
Early research (Phase 1)Study completedNCT01172054
What this trial is testing

Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
VaxInnate Corporation 292
Not applicableStudy completedNCT01040741
What this trial is testing

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Who this might be right for
Pandemic Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 7,284
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Large-scale testing (Phase 3)Study completedNCT00973700
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

Who this might be right for
Novel 2009 Influenza H1N1
Novartis Vaccines 784
Load More Results